• Dutch
    • German
  • DeltaStudy successfully completed

    In this multicenter study, 434 patients measured with DeltaScan

    A large scale validation study for DeltaScan device performance was executed. Patient data was collected from a wide study population of 434 patients. The aim of the study was to investigate the diagnostic performance of the DeltaScan, a CE-certified device to detect acute encephalopathy and delirium using a brief electroencephalography (EEG) recording, separately in patients admitted to an Intensive Care Unit (ICU), and elderly patient admitted to the ward (non-ICU department). The design of the study was a Cross-sectional, multicentre study in 9 hospitals with 31 different departments; nearly 50% of the patients were in the ICU, the better half of the patients were in a variety of wards (e.g. cardiothoracic surgery, geriatric traumatology, geriatrics, internal medicine, etc). The study results show strong performance (>85% overall diagnostic accuracy) of DeltaScan for acute encephalopathy (a.k.a. delirium) in the variety of hospital departments.

    DeltaScan® is an EU registered trademark (Certificate Nr 018280613)

    Prolira BV
    IJsselburcht 3
    6825 BS Arnhem
    The Netherlands

    Visiting address:
    Padualaan 8
    3584 CH Utrecht
    The Netherlands


    +31 (0)85 060 1656

    Prolira’s privacy statement
    Cookie statement